Drug Approval Package: JULUCA (dolutegravir and rilpivirine)
Company: ViiV Healthcare Company
Application Number: 210192
Approval Date: 11/21/2017
Application Number: 210192
Approval Date: 11/21/2017
Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.
FDA Approval Letter and Labeling
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
FDA Application Review Files
Date created: June 29, 2018
Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.
Note: Documents in PDF format require the Adobe Acrobat Reader®.